- DKK3.28bn
- DKK7.32bn
- DKK8.78bn
Brief: Matas Recalled Sun Products From Stores
Advisory: Alerts on takeover bid on Matas A/S withdrawn
Brief: Matas Q4 EBITDA Up At DKK 160 Million
Brief: Matas Appoints Mathias Juhl-Hansen As Interim CFO
Brief: Matas Appoints Per Johannesen Madsen As New Chief Financial Officer
Brief: Matas CFO To Step Down On June 1, 2022
Brief: Matas Q3 EBITDA Up At DKK 301 Mln
Brief: Matas Q3 2021/22 Rev Up At DKK 1.38 Bln, Upgrades FY Revenue Guidance
Brief: Matas Q2 EBITDA Before Special Items Falls To DKK 166 Mln
Brief: Matas Initiates New Share Buyback Program
Brief: Matas Q1 EBITDA Before Special Items Rises To DKK 186 Mln
Brief: Matas Q1 EBITDA Of DKK 797 Million
Brief: Novozymes A/S - Novozymes Enters Partnership With Danish Retailer
Brief: Matas Acquires Health Tech Platform And Enters Into Collaboration With Online Pharmacy
Brief: Matas Q3 EBITDA Ex. Items Up At DKK 292.8 Mln
Brief: Matas Oct-Dec Revenue Rises To DKK 1,313 Million
Brief: Matas Q2 EBITDA Before Special Items At DKK 179.6 Million
Brief: Matas Q1 EBIT Up At DKK 72.1 Mln
Brief: Matas A/S Says Board Of Directors Elected Lars Vinge Frederiksen Chairman And Lars Frederiksen Deputy Chairman Of Board